329 related articles for article (PubMed ID: 16522150)
61. The Use of Transgenic Animals in the European Union: The Report and Recommendations of ECVAM Workshop 28.
Mepham TB; Combes RD; Balls M; Barbieri O; Blokhuis HJ; Costa P; Crilly RE; de Cock Buning T; Delpire VC; O'Hare MJ; Houdebine LM; van Kreijl CF; van der Meer M; Reinhardt CA; Wolf E; van Zeller AM
Altern Lab Anim; 1998; 26(1):21-43. PubMed ID: 11656813
[No Abstract] [Full Text] [Related]
62. Integrated testing strategy (ITS) for bioaccumulation assessment under REACH.
Lombardo A; Roncaglioni A; Benfentati E; Nendza M; Segner H; Fernández A; Kühne R; Franco A; Pauné E; Schüürmann G
Environ Int; 2014 Aug; 69():40-50. PubMed ID: 24806447
[TBL] [Abstract][Full Text] [Related]
63. Regulatory toxicology: objectives and tasks defined by the working group of the German society of experimental and clinical pharmacology and toxicology.
Gelbke HP
Toxicol Lett; 2002 Feb; 126(3):159-60. PubMed ID: 11814701
[No Abstract] [Full Text] [Related]
64. Toxicology and stem cells: New frontiers.
Caloni F; Ferrari M; De Angelis I
ALTEX; 2014; 31(1):94. PubMed ID: 24448761
[No Abstract] [Full Text] [Related]
65. The way forward for reproductive/developmental toxicity testing.
Balls M
Altern Lab Anim; 2008 Dec; 36(6):713-4. PubMed ID: 19154098
[No Abstract] [Full Text] [Related]
66. [In vitro methods and safety testing of chemicals].
Louekari K; Salminen L; Tähti H
Duodecim; 1998; 114(9):851-8. PubMed ID: 11524804
[No Abstract] [Full Text] [Related]
67. Toxicology is IN: in silico, in vitro, integrated testing strategy.
Caloni F; Benfenati E; Sambuy Y
ALTEX; 2016; 33(2):187-8. PubMed ID: 27032091
[No Abstract] [Full Text] [Related]
68. [INVITOX 2002: 12th International workshop on in vitro toxicology].
Boess F; Scholz G; Spielman H
ALTEX; 2003; 20(1):36-9. PubMed ID: 12674101
[No Abstract] [Full Text] [Related]
69. Recent developments in in vitro toxicology: perspectives of European research and Tox21.
Marchan R; van Thriel C; Bolt HM
Arch Toxicol; 2013 Dec; 87(12):2043-6. PubMed ID: 24221536
[No Abstract] [Full Text] [Related]
70. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
Waddell WJ
Hum Exp Toxicol; 2010 Jan; 29(1):31-2. PubMed ID: 20061465
[TBL] [Abstract][Full Text] [Related]
71. Quantitative in vitro to in vivo extrapolation (QIVIVE): An essential element for in vitro-based risk assessment.
Yoon M; Blaauboer BJ; Clewell HJ
Toxicology; 2015 Jun; 332():1-3. PubMed ID: 25680635
[No Abstract] [Full Text] [Related]
72. Toxicology in the 21st century--working our way towards a visionary reality.
Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
[TBL] [Abstract][Full Text] [Related]
73. Introduction to the EU REACH legislation.
Grindon C; Combes R
Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
[TBL] [Abstract][Full Text] [Related]
74. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
Schwartz SL
Hum Exp Toxicol; 2010 Jan; 29(1):15-9. PubMed ID: 20061463
[TBL] [Abstract][Full Text] [Related]
75. A review of the implementation of the embryonic stem cell test (EST). The report and recommendations of an ECVAM/ReProTect Workshop.
Marx-Stoelting P; Adriaens E; Ahr HJ; Bremer S; Garthoff B; Gelbke HP; Piersma A; Pellizzer C; Reuter U; Rogiers V; Schenk B; Schwengberg S; Seiler A; Spielmann H; Steemans M; Stedman DB; Vanparys P; Vericat JA; Verwei M; van der Water F; Weimer M; Schwarz M
Altern Lab Anim; 2009 Jul; 37(3):313-28. PubMed ID: 19678733
[No Abstract] [Full Text] [Related]
76. Use of animals for toxicology testing is necessary to ensure patient safety in pharmaceutical development.
Mangipudy R; Burkhardt J; Kadambi VJ
Regul Toxicol Pharmacol; 2014 Nov; 70(2):439-41. PubMed ID: 25058855
[TBL] [Abstract][Full Text] [Related]
77. The need for a formal invalidation process for animal and non-animal tests.
Balls M; Combes R
Altern Lab Anim; 2005 Jun; 33(3):299-308. PubMed ID: 16180982
[TBL] [Abstract][Full Text] [Related]
78. The use of mechanisms and modes of toxic action in integrated testing strategies: the report and recommendations of a workshop held as part of the European Union OSIRIS Integrated Project.
Vonk JA; Benigni R; Hewitt M; Nendza M; Segner H; van de Meent D; Cronin MT
Altern Lab Anim; 2009 Nov; 37(5):557-71. PubMed ID: 20017584
[TBL] [Abstract][Full Text] [Related]
79. Guidance on good cell culture practice. a report of the second ECVAM task force on good cell culture practice.
Coecke S; Balls M; Bowe G; Davis J; Gstraunthaler G; Hartung T; Hay R; Merten OW; Price A; Schechtman L; Stacey G; Stokes W;
Altern Lab Anim; 2005 Jun; 33(3):261-87. PubMed ID: 16180980
[No Abstract] [Full Text] [Related]
80. Management of an integrated project (Sens-it-iv) to develop in vitro tests to assess sensitisation.
Rovida C; Basketter D; Casati S; de Silva O; Hermans H; Kimber I; Manou I; Weltzien HU; Roggen E
Altern Lab Anim; 2007 Jun; 35(3):317-22. PubMed ID: 17650950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
